Slowinska-Srzednicka, J <br/><br/>
Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.  [electronic resource] 

 -  Journal of endocrinological investigation   
 - 533-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0391-4097 
<br/><br/><label>Standard No.: </label>10.1007/BF03348801  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Administration, Oral<br/>Adult<br/>Chlormadinone Acetate--administration & dosage<br/>Dehydroepiandrosterone--analogs & derivatives<br/>Dehydroepiandrosterone Sulfate<br/>Drug Therapy, Combination<br/>Estradiol--administration & dosage<br/>Estrogen Replacement Therapy<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Immunoradiometric Assay<br/>Insulin-Like Growth Factor I--metabolism<br/>Luteinizing Hormone--blood<br/>Menopause<br/>Middle Aged<br/>Pituitary Gland--metabolism<br/>Radioimmunoassay<br/>Sex Hormone-Binding Globulin--metabolism<br/>Testosterone--blood